These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14630401)

  • 21. Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands.
    Rosado S; Rua-Figueroa I; Vargas JA; Garcia-Laorden MI; Losada-Fernandez I; Martin-Donaire T; Perez-Chacon G; Rodriguez-Gallego C; Naranjo-Hernandez A; Ojeda-Bruno S; Citores MJ; Perez-Aciego P
    Int J Immunogenet; 2008 Jun; 35(3):235-42. PubMed ID: 18397303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The brain-derived neutrophic factor val66met polymorphism and sudden unexpected infant death.
    Opdal SH; Melien O; Hynnekleiv T; Rognum TO
    Acta Paediatr; 2011 Jan; 100(1):86-9. PubMed ID: 20653606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 10 genotype as a risk factor for sudden infant death syndrome: determination of IL-10 genotype from wax-embedded postmortem samples.
    Korachi M; Pravica V; Barson AJ; Hutchinson IV; Drucker DB
    FEMS Immunol Med Microbiol; 2004 Sep; 42(1):125-9. PubMed ID: 15325405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms of IL-10 gene in patients infected with HCV under antiviral treatment in southern Brazil.
    da Silva NM; Germano FN; Vidales-Braz BM; Carmo Zanella Rd; dos Santos DM; Lobato R; de Martinez AM
    Cytokine; 2015 Jun; 73(2):253-7. PubMed ID: 25797191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
    Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
    Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response.
    Schotte H; Gaubitz M; Willeke P; Tidow N; Assmann G; Domschke W; Schlüter B
    Rheumatology (Oxford); 2004 Nov; 43(11):1357-63. PubMed ID: 15304673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-10 microsatellite variants and the risk of acute coronary syndrome among Tunisians.
    Ben-Hadj-Khalifa-Kechiche S; Cornillet-Lefebvre P; Gillot L; Abboud N; Ben-Khalfallah A; Addad F; Almawi WY; Mahjoub T
    Int J Immunogenet; 2011 Feb; 38(1):37-43. PubMed ID: 20807264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus.
    Chong WP; Ip WK; Wong WH; Lau CS; Chan TM; Lau YL
    Genes Immun; 2004 Sep; 5(6):484-92. PubMed ID: 15295621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency distribution of interleukin-10 haplotypes (-1082 A>G, -819 C>T, and -592 C>A) in a Mexican population.
    Vázquez-Villamar M; Palafox-Sánchez CA; Hernández-Bello J; Muñoz-Valle JF; Valle Y; Cruz A; Alatorre-Meza AI; Oregon-Romero E
    Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27819740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus.
    Eskdale J; Keijsers V; Huizinga T; Gallagher G
    Genes Immun; 1999 Nov; 1(2):151-5. PubMed ID: 11196662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.
    Eder T; Mayer R; Langsenlehner U; Renner W; Krippl P; Wascher TC; Pummer K; Kapp KS
    Eur J Cancer; 2007 Feb; 43(3):472-5. PubMed ID: 17182240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection.
    Knapp S; Hennig BJ; Frodsham AJ; Zhang L; Hellier S; Wright M; Goldin R; Hill AV; Thomas HC; Thursz MR
    Immunogenetics; 2003 Sep; 55(6):362-9. PubMed ID: 12942209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variation in the monoamine oxidase A and serotonin transporter genes in sudden infant death syndrome.
    Opdal SH; Vege Å; Rognum TO
    Acta Paediatr; 2014 Apr; 103(4):393-7. PubMed ID: 24286237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA).
    Möller JC; Paul D; Ganser G; Range U; Gahr M; Kelsch R; Rösen-Wolff A; Hedrich CM
    Clin Exp Rheumatol; 2010; 28(6):912-8. PubMed ID: 21205466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL10 promoter haplotypes may contribute to altered cytokine expression and systemic inflammation in celiac disease.
    Hofmann SR; Laass MW; Fehrs A; Schuppan D; Zevallos VF; Salminger D; Mäbert K; Hedrich CM
    Clin Immunol; 2018 May; 190():15-21. PubMed ID: 29481982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there any correlation between HLA-DR expression in laryngeal mucosa and interleukin gene variation in sudden infant death syndrome?
    Ferrante L; Opdal SH; Vege A; Rognum TO
    Acta Paediatr; 2013 Mar; 102(3):308-13. PubMed ID: 23186119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma.
    Karjalainen J; Hulkkonen J; Nieminen MM; Huhtala H; Aromaa A; Klaukka T; Hurme M
    Clin Exp Allergy; 2003 Jan; 33(1):78-83. PubMed ID: 12534553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a genetic component in sudden infant death syndrome.
    Gordon AE; MacKenzie DA; El Ahmer OR; Al Madani OM; Braun JM; Weir DM; Busuttil A; Blackwell CC
    Child Care Health Dev; 2002 Sep; 28 Suppl 1():27-9. PubMed ID: 12515435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of dopamine transporter and monoamine oxidase molecular polymorphisms with sudden infant death syndrome and stillbirth: new insights into the serotonin hypothesis.
    Filonzi L; Magnani C; Lavezzi AM; Rindi G; Parmigiani S; Bevilacqua G; Matturri L; Marzano FN
    Neurogenetics; 2009 Feb; 10(1):65-72. PubMed ID: 18810510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine responses and sudden infant death syndrome: genetic, developmental, and environmental risk factors.
    Blackwell CC; Moscovis SM; Gordon AE; Al Madani OM; Hall ST; Gleeson M; Scott RJ; Roberts-Thomson J; Weir DM; Busuttil A
    J Leukoc Biol; 2005 Dec; 78(6):1242-54. PubMed ID: 16204631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.